経鼻ドラッグデリバリー技術の世界市場レポート 2024年

経鼻ドラッグデリバリー技術市場規模は近年力強く成長しています。2023年の774億2,000万米ドルから2024年には829億8,000万米ドルへと、CAGR7.2％で拡大します。これまでの成長の背景には、薬剤製剤の進歩、呼吸器疾患の有病率の増加、非侵襲的デリバリー法への患者の傾斜、高齢者人口の拡大、経鼻薬物治療の承認に対する規制当局の後押しなど、いくつかの要因があります。

慢性疾患の急増が予想されることから、経鼻ドラッグデリバリー技術市場の拡大が見込まれます。これらの疾患は1年以上持続し、継続的な医学的治療を必要とするため、効率的な治療法に対する需要が生じています。経鼻ドラッグデリバリー技術は、特に慢性鼻副鼻腔炎をターゲットとしており、鼻腔内の複雑な状態に対処する治療戦略を活用しています。2022年9月の米国国立衛生研究所の報告書によると、米国では2050年までに少なくとも1つの慢性疾患を持つ50歳以上の患者が100％近く増加すると予測されており、経鼻ドラッグデリバリーシステムの成長を促しています。

2023年の経鼻ドラッグデリバリー技術市場で最大の地域は北米でした。経鼻ドラッグデリバリー技術市場レポートの対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の経鼻ドラッグデリバリー技術市場、剤形別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 鼻腔用スプレー
• 点鼻薬
• 鼻ジェルと軟膏
• 鼻腔用粉剤
• その他の剤形
• 世界の経鼻ドラッグデリバリー技術市場、容器タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 加圧容器
• 非加圧容器
• 世界の経鼻ドラッグデリバリー技術市場、治療用途別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• アレルギー性鼻炎・非アレルギー性鼻炎
• 鼻詰まり
• 喘息
• 予防接種
• その他の治療用途
• 世界の経鼻ドラッグデリバリー技術市場、流通チャネル別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の経鼻ドラッグデリバリー技術市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 在宅ケア環境
• 病院

第7章 地域および国の分析

• 世界の経鼻ドラッグデリバリー技術市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の経鼻ドラッグデリバリー技術市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 経鼻ドラッグデリバリー技術市場の競合情勢
• 経鼻ドラッグデリバリー技術市場の企業プロファイル
  • AptarGroup Inc.
  • Becton Dickinson and Company
  • GlaxoSmithKline plc
  • Johnson &Johnson Private Limited
  • Novartis AG

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Nasal Drug Delivery Technology Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nasal drug delivery technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nasal drug delivery technology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The nasal drug delivery technology market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Dosage Form: Nasal Spray; Nasal Drops; Nasal Gels And Ointments; Nasal Powders; Other Dosage Forms
• 2) By Container Type: Pressurized Containers; Non-Pressurized Containers
• 3) By Therapeutic Application: Allergic And Non-Allergic Rhinitis; Nasal Congestion; Asthma; Vaccination; Other Therapeutic Applications
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End User: Home Care Settings; Hospitals
• Companies Mentioned: AptarGroup Inc.; Becton Dickinson and Company; GlaxoSmithKline plc; Johnson & Johnson Private Limited; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Nasal drug delivery technology involves administering pharmaceuticals through the nasal cavity, aiming to rapidly achieve therapeutic drug levels in the bloodstream and potentially enable direct drug delivery to the brain via olfactory neurons. This method bypasses the blood-brain barrier (BBB) and undergoes minimal processing in the liver and intestines.

Key dosage forms for this technology include nasal spray, nasal drops, nasal gels, ointments, powders, and others. Nasal spray devices expel numerous tiny liquid drops to cleanse the nose or deliver medication to the body. They are available in pressurized and non-pressurized containers and are applied across diverse uses such as allergic and non-allergic rhinitis, nasal congestion, asthma, vaccination, and more. These products are accessible through various distribution channels such as hospital pharmacies, retail outlets, and online pharmacies, and are utilized by end-users including home care settings and hospitals.

The nasal drug delivery technology market research report is one of a series of new reports from The Business Research Company that provides nasal drug delivery technology market statistics, including nasal drug delivery technology industry global market size, regional shares, competitors with a nasal drug delivery technology market share, detailed nasal drug delivery technology market segments, market trends, and opportunities, and any further data you may need to thrive in the nasal drug delivery technology industry. This nasal drug delivery technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nasal drug delivery technology market size has grown strongly in recent years. It will grow from $77.42 billion in 2023 to $82.98 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. Historical growth can be credited to several factors, including advancements in drug formulations, a growing prevalence of respiratory disorders, patient inclination toward non-invasive delivery methods, the expanding population of older adults, and regulatory backing for approvals of nasal drug treatments.

The nasal drug delivery technology market size is expected to see strong growth in the next few years. It will grow to $110.08 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. Anticipated growth in the forthcoming period is linked to the upsurge in biologics and peptide therapies, heightened attention to meeting the needs of pediatric and geriatric patients, increased partnerships and collaborations within the pharmaceutical industry, the broadening scope of over-the-counter (OTC) nasal products, and a heightened focus on precision medicine.

The anticipated surge in chronic diseases is expected to drive the expansion of the nasal drug delivery technology market. These conditions, lasting over a year and requiring ongoing medical attention, create demand for efficient treatment methods. Nasal drug delivery technologies specifically target chronic rhinosinusitis, leveraging therapeutic strategies to address complexities within the nasal cavity. According to a report by the National Institutes of Health in September 2022, projections for the United States estimate a nearly 100% increase in individuals aged 50 and older with at least one chronic illness by 2050, stimulating the growth of nasal drug delivery systems.

The escalating global geriatric population is poised to significantly propel the nasal drug delivery technology market. With individuals aged 65 and above, nasal drug delivery methods present advantages in ease of administration and improved patient compliance, particularly addressing challenges related to pill swallowing among the elderly. As projected by the World Health Organization in October 2022, the global population of those aged 60 years and older is anticipated to reach 1.4 billion by 2022, with one in six individuals expected to fall within this age group by 2030. This demographic shift drives the market's growth for nasal drug delivery technology.

Product innovation stands as a pivotal trend shaping the landscape of nasal drug delivery technology. Leading pharmaceutical companies are actively engaged in developing novel drug administration methods to bolster their market positions. For instance, in January 2023, AptarGroup, Inc. introduced APF Futurity, the first recyclable, metal-free, multidose nasal spray designed for nasal saline and equivalent OTC formulations. This innovative product's recyclability design has garnered Class AA certification, promoting greater recycling efficiency.

Collaborative efforts aimed at technological advancements highlight the strategic focus within the nasal drug delivery sector. Notably, in November 2023, Hovione collaborated with Industrial Design Consultancy (IDC) to develop advanced nasal powder delivery devices. These devices offer precise drug delivery options for local, systemic, or nose-to-brain applications, showcasing versatility and reliability. The collaboration's objective is to expedite the release of two innovative nasal powder delivery devices, catering to diverse drug delivery needs while streamlining drug product development and manufacturing processes.

In May 2022, Medtronic plc, a US-based medical device firm, acquired Intersect ENT Inc. for an undisclosed sum. The acquisition will add novel products used in sinus operations to enhance post-operative outcomes and treat nasal polyps to Medtronic's entire ear, nose, and throat (ENT) portfolio. Intersect ENT Inc. is a US-based medical device firm operating in ear, nose, and throat medical technology.

Major companies operating in the nasal drug delivery technology market report are AptarGroup Inc., Becton Dickinson and Company, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Novartis AG, Pfizer Inc., 3M Company, Cadila Healthcare Limited, Neurelis Inc., OptiNose Inc., Bausch Health Companies Inc., Naveh Pharma Ltd., Teva Pharmaceutical Industries Ltd., Consort Medical plc, Douglas Pharmaceuticals Ltd., ENT Technologies Pty. Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Boehringer Ingelheim International GmbH, Bayer AG, Abbott Laboratories, Eli Lilly and Company, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Amgen Inc., Gilead Sciences Inc., Biogen Inc., Roche Holding AG, Allergan plc, Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals Inc.

North America was the largest region in the nasal drug delivery technology market in 2023. The regions covered in the nasal drug delivery technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the nasal drug delivery technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The nasal drug delivery technology market consists of revenues earned by entities by providing services such as intranasal drug delivery services, brain-targeted therapy, and mucosal vaccination. The market value includes the value of related goods sold by the service provider or included within the service offering. The nasal drug delivery technology market also includes sales of catheter-delivered drugs, nebulizers, and pressurized metered-dose inhalers (PMDIs) equipment which are used in providing nasal drug delivery technology services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Nasal Drug Delivery Technology Market Characteristics

3. Nasal Drug Delivery Technology Market Trends And Strategies

4. Nasal Drug Delivery Technology Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Nasal Drug Delivery Technology Market Size and Growth

• 5.1. Global Nasal Drug Delivery Technology Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Nasal Drug Delivery Technology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Nasal Drug Delivery Technology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Nasal Drug Delivery Technology Market Segmentation

• 6.1. Global Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Nasal Spray
• Nasal Drops
• Nasal Gels And Ointments
• Nasal Powders
• Other Dosage Forms
• 6.2. Global Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pressurized Containers
• Non-Pressurized Containers
• 6.3. Global Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Allergic And Non-Allergic Rhinitis
• Nasal Congestion
• Asthma
• Vaccination
• Other Therapeutic Applications
• 6.4. Global Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Home Care Settings
• Hospitals

7. Nasal Drug Delivery Technology Market Regional And Country Analysis

• 7.1. Global Nasal Drug Delivery Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Nasal Drug Delivery Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Nasal Drug Delivery Technology Market

• 8.1. Asia-Pacific Nasal Drug Delivery Technology Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Nasal Drug Delivery Technology Market

• 9.1. China Nasal Drug Delivery Technology Market Overview
• 9.2. China Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Nasal Drug Delivery Technology Market

• 10.1. India Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Nasal Drug Delivery Technology Market

• 11.1. Japan Nasal Drug Delivery Technology Market Overview
• 11.2. Japan Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Nasal Drug Delivery Technology Market

• 12.1. Australia Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Nasal Drug Delivery Technology Market

• 13.1. Indonesia Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Nasal Drug Delivery Technology Market

• 14.1. South Korea Nasal Drug Delivery Technology Market Overview
• 14.2. South Korea Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Nasal Drug Delivery Technology Market

• 15.1. Western Europe Nasal Drug Delivery Technology Market Overview
• 15.2. Western Europe Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Nasal Drug Delivery Technology Market

• 16.1. UK Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Nasal Drug Delivery Technology Market

• 17.1. Germany Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Nasal Drug Delivery Technology Market

• 18.1. France Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Nasal Drug Delivery Technology Market

• 19.1. Italy Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Nasal Drug Delivery Technology Market

• 20.1. Spain Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Nasal Drug Delivery Technology Market

• 21.1. Eastern Europe Nasal Drug Delivery Technology Market Overview
• 21.2. Eastern Europe Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Nasal Drug Delivery Technology Market

• 22.1. Russia Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Nasal Drug Delivery Technology Market

• 23.1. North America Nasal Drug Delivery Technology Market Overview
• 23.2. North America Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Nasal Drug Delivery Technology Market

• 24.1. USA Nasal Drug Delivery Technology Market Overview
• 24.2. USA Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Nasal Drug Delivery Technology Market

• 25.1. Canada Nasal Drug Delivery Technology Market Overview
• 25.2. Canada Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Nasal Drug Delivery Technology Market

• 26.1. South America Nasal Drug Delivery Technology Market Overview
• 26.2. South America Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Nasal Drug Delivery Technology Market

• 27.1. Brazil Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Nasal Drug Delivery Technology Market

• 28.1. Middle East Nasal Drug Delivery Technology Market Overview
• 28.2. Middle East Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Nasal Drug Delivery Technology Market

• 29.1. Africa Nasal Drug Delivery Technology Market Overview
• 29.2. Africa Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Nasal Drug Delivery Technology Market Competitive Landscape And Company Profiles

• 30.1. Nasal Drug Delivery Technology Market Competitive Landscape
• 30.2. Nasal Drug Delivery Technology Market Company Profiles
  • 30.2.1. AptarGroup Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Becton Dickinson and Company
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. GlaxoSmithKline plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Johnson & Johnson Private Limited
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Novartis AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Nasal Drug Delivery Technology Market Competitive Benchmarking

32. Global Nasal Drug Delivery Technology Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Nasal Drug Delivery Technology Market

34. Nasal Drug Delivery Technology Market Future Outlook and Potential Analysis

• 34.1 Nasal Drug Delivery Technology Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Nasal Drug Delivery Technology Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Nasal Drug Delivery Technology Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer